CA2375560A1 - Manufacturing method for intravenous immune globulin and resultant product - Google Patents

Manufacturing method for intravenous immune globulin and resultant product Download PDF

Info

Publication number
CA2375560A1
CA2375560A1 CA002375560A CA2375560A CA2375560A1 CA 2375560 A1 CA2375560 A1 CA 2375560A1 CA 002375560 A CA002375560 A CA 002375560A CA 2375560 A CA2375560 A CA 2375560A CA 2375560 A1 CA2375560 A1 CA 2375560A1
Authority
CA
Canada
Prior art keywords
gamma globulin
solution
globulin solution
detergent
fraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002375560A
Other languages
English (en)
French (fr)
Inventor
Raja R. Mamidi
Andranik Bagdasarian
Gorgonio Canaveral
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alpha Therapeutic Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2375560A1 publication Critical patent/CA2375560A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
CA002375560A 1999-06-15 2000-06-06 Manufacturing method for intravenous immune globulin and resultant product Abandoned CA2375560A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33328999A 1999-06-15 1999-06-15
US09/333,289 1999-06-15
PCT/US2000/011870 WO2000076534A1 (en) 1999-06-15 2000-06-06 Manufacturing method for intravenous immune globulin and resultant product

Publications (1)

Publication Number Publication Date
CA2375560A1 true CA2375560A1 (en) 2000-12-21

Family

ID=23302162

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002375560A Abandoned CA2375560A1 (en) 1999-06-15 2000-06-06 Manufacturing method for intravenous immune globulin and resultant product

Country Status (13)

Country Link
EP (1) EP1185290A4 (cs)
JP (1) JP2003501480A (cs)
KR (1) KR20020010921A (cs)
CN (1) CN1358100A (cs)
AU (1) AU756071B2 (cs)
BR (1) BR0011648A (cs)
CA (1) CA2375560A1 (cs)
CZ (1) CZ20014456A3 (cs)
HK (1) HK1048252A1 (cs)
IL (1) IL146433A0 (cs)
PL (1) PL352910A1 (cs)
WO (1) WO2000076534A1 (cs)
ZA (1) ZA200110168B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2437518A (en) * 2006-04-26 2007-10-31 Noel Kavanagh Antiserum preparation
WO2007136327A1 (en) * 2006-05-22 2007-11-29 Ge Healthcare Bio-Sciences Ab A method of producing igg
US7932356B1 (en) * 2010-06-23 2011-04-26 Bing Lou Wong Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition
ES2785375T3 (es) 2014-03-11 2020-10-06 Green Cross Holdings Corp Procedimiento de purificación de inmunoglobulina
CA2941232C (en) * 2014-03-11 2020-08-25 Green Cross Holdings Corporation Method for purifying immunoglobulin
KR101941974B1 (ko) * 2016-11-18 2019-01-24 주식회사 녹십자 혈장 단백질 정제시 fxi의 제거방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
FR2582515B1 (fr) * 1985-05-30 1988-11-04 Merieux Inst Procede de preparation de gamma-gobulines administrables par voie intraveineuse et gamma-globulines obtenues
JPH0662436B2 (ja) * 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
US4841023A (en) * 1986-06-25 1989-06-20 New York Blood Center, Inc. Inactivation of viruses in labile protein-containing compositions using fatty acids
DE69011136T3 (de) * 1989-01-13 2003-10-23 Mitsubishi Pharma Corp Verfahren zur Herstellung einer Protein enthaltenden Zusammensetzung.
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
JP3145696B2 (ja) * 1990-10-05 2001-03-12 日本ケミカルリサーチ株式会社 分泌型免疫グロブリンａ製剤の製造法
US5110910A (en) * 1991-03-25 1992-05-05 Miles Inc. Virucidal euglobulin precipitation
DE4431833C1 (de) * 1994-09-07 1995-05-18 Blutspendedienst Der Drk Lande Verfahren zur Herstellung eines AHF-Konzentrates
UA64742C2 (uk) * 1997-12-24 2004-03-15 Альфа Терапевтик Корпорейшн СПОСІБ ОДЕРЖАННЯ РОЗЧИНУ <font face="Symbol">g</font>-ГЛОБУЛІНУ, ПРИЗНАЧЕНОГО ДЛЯ ВНУТРІШНЬОВЕННОГО ВВЕДЕННЯ, І ПРОДУКТ, ЩО ОДЕРЖУЄТЬСЯ У ЦЕЙ СПОСІБ (ВАРІАНТИ)

Also Published As

Publication number Publication date
WO2000076534A1 (en) 2000-12-21
IL146433A0 (en) 2002-07-25
ZA200110168B (en) 2002-08-26
HK1048252A1 (zh) 2003-03-28
AU756071B2 (en) 2003-01-02
PL352910A1 (en) 2003-09-22
CZ20014456A3 (cs) 2002-05-15
AU5722400A (en) 2001-01-02
KR20020010921A (ko) 2002-02-06
EP1185290A1 (en) 2002-03-13
JP2003501480A (ja) 2003-01-14
CN1358100A (zh) 2002-07-10
EP1185290A4 (en) 2005-08-31
BR0011648A (pt) 2002-03-19

Similar Documents

Publication Publication Date Title
JP5042817B2 (ja) ウイルス安全精製抗体調製物を提供する方法
KR20070009995A (ko) 바이러스 안전성 면역글로불린을 제조하는 방법
WO1999033486A1 (en) Composition and method for dermal and transdermal administration of a cytokine
SK287633B6 (sk) Spôsob výroby humánneho gamaglobulínu G a humánny gamaglobulín G s inaktivovanými vírusmi
US20060177909A1 (en) Preparation of immunoglobulin
US6162904A (en) Manufacturing method for intraveneously administrable immune globulin and resultant product
AU747893B2 (en) Production process for intravenous immune serum globulin and resultant product
US6504012B2 (en) Method for preparing dual virally inactivated immune globulin for intravenous administration
TW201307384A (zh) 多價免疫球蛋白之濃縮物之製造方法
AU756071B2 (en) Manufacturing method for intravenous immune globulin and resultant product
JP2008094722A (ja) 免疫グロブリン製剤の製造方法
MXPA99007835A (en) Production process for intravenous immune serum globulin and resultant product
CZ293499A3 (cs) Způsob přípravy intravenózně aplikovatelného roztoku gammaglobulinu a výsledný produkt

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued
FZDE Discontinued

Effective date: 20100302